Met Life Investment Management, LLC Igm Biosciences, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 8,997 shares of IGMS stock, worth $62,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,997

Holding current value

$62,079

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $17.68 $56,501 - $159,066	8,997 New	8,997 $148,000
Q1 2024 May 14, 2024	BUY	$8.68 - $17.36 $62,912 - $125,825	7,248 New	7,248 $69,000
Q1 2023 May 09, 2024	BUY	$13.74 - $25.76 $78,345 - $146,883	5,702 New	5,702 $78.3 Million
Q4 2022 Jun 14, 2023	BUY	$15.45 - $26.02 $88,095 - $148,366	5,702 New	5,702 $96,000
Q3 2022 May 10, 2024	BUY	$15.42 - $27.01 $4,718 - $8,265	306 Added 5.67%	5,702 $129,000
Q3 2022 Jun 14, 2023	BUY	$15.42 - $27.01 $87,924 - $154,011	5,702 New	5,702 $129,000
Q3 2022 Mar 22, 2023	BUY	$15.42 - $27.01 $4,718 - $8,265	306 Added 5.67%	5,702 $129,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $4,718 - $8,265	306 Added 5.67%	5,702 $130,000
Q2 2022 May 10, 2024	BUY	$13.27 - $25.5 $71,604 - $137,598	5,396 New	5,396 $97,000
Q2 2022 Jun 20, 2023	BUY	$13.27 - $25.5 $71,604 - $137,598	5,396 New	5,396 $97,000
Q2 2022 Mar 22, 2023	BUY	$13.27 - $25.5 $27,376 - $52,606	2,063 Added 61.9%	5,396 $97,000
Q2 2022 Aug 11, 2022	BUY	$13.27 - $25.5 $71,604 - $137,598	5,396 New	5,396 $97,000
Q1 2022 May 12, 2022	SELL	$13.42 - $29.73 $44,728 - $99,090	-3,333 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$27.59 - $66.39 $91,957 - $221,277	3,333 New	3,333 $97,000
Q3 2021 Jun 21, 2023	BUY	$65.76 - $90.65 $219,178 - $302,136	3,333 New	3,333 $219,000
Q1 2021 May 17, 2024	SELL	$71.56 - $121.23 $280,157 - $474,615	-3,915 Reduced 54.01%	3,333 $255,000
Q1 2021 Jun 26, 2023	BUY	$71.56 - $121.23 $238,509 - $404,059	3,333 New	3,333 $256 Million
Q4 2020 Jun 22, 2023	BUY	$47.41 - $115.03 $158,017 - $383,394	3,333 New	3,333 $294,000
Q3 2020 Jun 26, 2023	BUY	$43.0 - $84.01 $143,319 - $280,005	3,333 New	3,333 $246,000
Q2 2020 May 24, 2024	SELL	$51.3 - $75.21 $200,839 - $294,447	-3,915 Reduced 54.01%	3,333 $243 Million
Q2 2020 Jun 26, 2023	BUY	$51.3 - $75.21 $170,982 - $250,674	3,333 New	3,333 $243,000
Q2 2020 Mar 22, 2023	BUY	$51.3 - $75.21 $45,964 - $67,388	896 Added 36.77%	3,333 $243,000
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $45,964 - $67,388	896 Added 36.77%	3,333 $243,000
Q1 2020 Jul 12, 2023	BUY	$31.51 - $73.75 $76,789 - $179,728	2,437 New	2,437 $136,000
Q1 2020 Mar 22, 2023	SELL	$31.51 - $73.75 $102,880 - $240,793	-3,265 Reduced 57.26%	2,437 $136,000
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $76,789 - $179,728	2,437 New	2,437 $137,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $200M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Igm Biosciences, Inc. Transaction History